{{ phone }} {{ location }}

Emergo by UL logo

    

Regulatory Consulting

It is easy to make mistakes in the regulatory process that can delay market entry or incur unnecessary costs. With help from Emergo’s medical device regulatory consultants, you can pursue the most efficient regulatory route to approval and registration for your device, and maintain compliance with post-market requirements worldwide.

Medical device and IVD classification determination and assessments

Classifying your medical device is an important first step in the device registration process. Your device class dictates its regulatory roadmap, including required documentation, clinical data and study requirements, safety testing requirements, and more.

We have experience classifying medical devices according to rules in the US, Europe, Japan, Brazil, Canada, and many other markets. Our team performs the toughest classification assessments for novel, borderline, and combination products. If needed, we will work with you to seek feedback from regulatory authorities on the appropriate classification for your product through pre-submission meetings.

Navigate complex medical device and IVD regulatory requirements

Medical device companies face an evolving regulatory landscape: market entry comes with more challenges than ever and maintaining compliance requires ongoing effort. Our consultants bring deep familiarity with opaque regulatory processes, such as:

And much more. Explore all our regulatory consulting services.

Global market strategy for medical device companies

Because we work in so many different markets, we fully understand complex national regulations and where they overlap. We apply this knowledge for your benefit in a way that could not be achieved by working with separate consultancies or affiliates with limited local expertise. We will develop customized regulatory strategies that leverage your existing registrations. Whether you have one product or hundreds, we can help you expand your market reach to major and emerging markets worldwide.

有任何问题? 向我们的专家获取相关信息

联系我们>

REGISTER NOW: To Err is Human: A Documentary Film Screening and Discussion on Preventing Human Errors in Medical Technology, Mar 7, 2019 to Mar 7, 2019 in Waltham, USA

FIND OUT MORE >

Regulatory Consulting

Australia | Regulatory Consulting

澳大利亚的医疗器械警戒通报

Australia | Regulatory Consulting

澳大利亚医疗器械监管环境概述

Brazil | Regulatory Consulting

在巴西向ANVISA进行医疗器械警戒报告

Brazil | Regulatory Consulting

在巴西的医疗器械监管策略报告

Brazil | Regulatory Consulting

巴西ANVISA医疗器械分类咨询

Canada | Regulatory Consulting

加拿大卫生部医疗器械不良事件报告

Canada | Regulatory Consulting

加拿大医疗器械分类咨询服务

Canada | Regulatory Consulting

加拿大医疗器械监管国家报告

China | Regulatory Consulting

中国医疗器械监管策略报告

Colombia | Regulatory Consulting

在哥伦比亚的医疗器械监管策略报告

Costa Rica | Regulatory Consulting

在哥斯达黎加的医疗器械监管策略报告

Egypt | Regulatory Consulting

埃及医疗器械策略报告

Europe | Regulatory Consulting

欧洲的医疗器械警戒信息与事故报告

Europe | Regulatory Consulting

针对EU医疗器械监管规定的CE标志培训

Hong Kong | Regulatory Consulting

在香港的医疗器械监管策略报告

India | Regulatory Consulting

在印度的医疗器械监管策略报告

Israel | Regulatory Consulting

以色列医疗器械监管策略报告

Japan | Regulatory Consulting

在日本的医疗器械监管策略报告

Japan | Regulatory Consulting

日本医疗器械费用报销咨询

Mexico | Regulatory Consulting

在墨西哥的医疗器械警戒报告

Mexico | Regulatory Consulting

在墨西哥的医疗器械分类

Mexico | Regulatory Consulting

在墨西哥的医疗器械监管策略报告

Peru | Regulatory Consulting

秘鲁医疗器械策略报告

Saudi Arabia | Regulatory Consulting

沙特阿拉伯的医疗器械监管策略报告

Singapore | Regulatory Consulting

新加坡医疗器械警戒报告

Singapore | Regulatory Consulting

新加坡的医疗器械分类

Singapore | Regulatory Consulting

在新加坡的医疗器械监管策略报告